Category Thesis Builder turns a scattered product and proof estate into a cleaner market thesis. It helps leadership decide what category to claim, what timing story to tell, what wedge is actually defensible, and what should stay out of the lead narrative until evidence catches up.
Agent adoption is accelerating faster than governance muscle, so buyers need a board-readable control layer now rather than after an incident.
Boards are pressing engineering leaders to show savings without stalling growth, which favors operator-grade margin intelligence over tooling sprawl.
Identity incidents, SaaS sprawl, and AI-tool access drift are expanding faster than most executive teams can explain them cleanly.
Revenue leaders are under pressure to prove pipeline quality and attribution trust as AI search, experimentation, and reporting stacks keep fragmenting.
Payment pressure, KYC refresh burden, and margin scrutiny are converging, which makes control-plane intelligence easier to justify than point tooling.
Biotech buyers and investors increasingly need software that translates quality complexity into funding, diligence, and release confidence.
Foundations and nonprofit operators are being pushed to show measurable outcomes and cleaner stewardship narratives under tighter budgets.
Automation adoption is climbing, but boards still lack simple language for override safety and operational readiness risk.